Stay updated on Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 to the history and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:07:19.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The history now shows a new Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-25T19:43:54.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    History shows a new revision entry v3.4.3 and removal of v3.4.2, indicating a small backend update to the page.
    Difference
    0.1%
    Check dated 2026-03-11T14:27:52.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    In the version history, 2026-02-12 adds Contacts/Locations and Study Status, and 2026-01-26 adds the entry 54; a deletion occurred on 2025-09-16.
    Difference
    0.3%
    Check dated 2026-02-18T06:50:21.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    A new version entry 'Revision: v3.4.2' was added to the version history, and notices including a government funding lapse message and 'Revision: v3.4.1' were removed. These changes are administrative and do not alter core page content or study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T04:49:58.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and NIH operating status was added, and the revision label updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T03:29:09.000Z thumbnail image

Stay in the know with updates to Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial page.